3 Public Cannabis Companies with Operations In Illinois

On May 31, 2019, Illinois lawmakers voted to officially legalize recreational cannabis in the state. The move makes Illinois the eleventh U.S. state to have legalized recreational marijuana for adult-use. Illinois Governor J.B. Pritzker took office in January 2019, after winning the election on a pro-legalization stance and making the issue a key campaign promise. The bill awaits a final…

Read More

Watch This as Aurora Cannabis (TSX:ACB) Targets Positive Earnings This Quarter

Last month, Aurora Cannabis (TSX:ACB)(NYSE:ACB) management reiterated its guidance for a positive EBITDA beginning this current quarter ending June 30. Such an achievement could be a huge confidence booster to the marijuana investing public, which has placed astronomical valuation multiples on the growth stock. Could this noble target be achievable this quarter? There are a lot of moving parts that…

Read More

3 Reasons Aurora Cannabis (TSX:ACB) Q3 Results Weren’t All That Impressive

Aurora Cannabis Inc  (TSX:ACB)(NYSE:ACB) hit $65 million in net revenue in its most recent quarter. It was quadruple the $16 million in sales that the company did a year ago, but that doesn’t tell the whole story. Here are my three takeaways from the company’s Q3 results. Sales were up, but still not where they were supposed to be Investors…

Read More

Why Did Cronos Group (TSX:CRON) Stock Trade 9% Lower After Q1 Earnings on Thursday?

Cannabis producer Cronos Group (TSX:CRON)(NASDAQ:CRON) shares traded as low as 9.6% on Thursday after the cash-rich company released a mixed bag of Q1 2019 results before market open. The company actually showed some improvements in its financial performance as compared to a previous quarter, but revenue growth, the market’s main focus today, was much weaker than desirable. Not-so-impressive revenue growth…

Read More

Meet the Canopy Growth (TSX:WEED) of Finance Stocks

Canopy Growth Corp  (TSX:WEED)(NYSE:CGC) is a giant in the cannabis space. As the largest cannabis producer by revenue and market cap, it’s by far the dominant player in its industry. Canopy’s low-cost production, large-scale grow space and strong retail presence have positioned it to remain #1 in its industry for the foreseeable future. These factors alone are enough to make…

Read More

Will Canopy Growth Corp (TSX:WEED) Hit $1 Billion in Sales Next Year?

Remember the Canopy Growth Corp  (TSX:WEED)(NYSE:CGC)/Constellation Brands  (NYSE:STZ) acquisition? Last year, it was one of the biggest stories in the Canadian markets. After months of legalization hype, Constellation announced in August that it would be acquiring a huge $5 billion stake in Canopy, bringing its total ownership to 35%. The acquisition began a massive rally in weed stocks that raised not…

Read More

HEXO Corp. (TSX:HEXO): The Next Big Thing for Canadian Cannabis?

Hexo (TSX:HEXO) has been one of the biggest winners in the cannabis space so far, shooting up 11% last week and almost doubling since the start of 2019. While overshadowed by other major cannabis companies, Hexo has silently positioned itself to become the next major player in the Canadian cannabis industry. Last week, Bank of America Merrill Lynch analyst Christopher…

Read More

Aphria Inc (TSX:APHA) Is Sinking Fast: Is Now the Time to Buy Low?

Nothing earthshaking happened when Aphria (TSX:APHA)(NYSE:APHA) reported its latest quarterly earnings, except for the sharp drop in the stock price. That pattern has been same whenever cannabis producers present their earnings results. Every story is predictable — whopping revenues and a mountain of losses. For the first time, Aphria’s earnings results included a full quarter of adult-use sales. APHA sunk…

Read More

Aphria Inc. (TSX:APHA) Disappoints: Is the Stock Price Attractive Today?

I have long written about the problem with cannabis stocks and their valuations and the expectations that are built into them. I’ve also written about the strong likelihood that higher-than-expected spending, shareholder dilution, and slower-than-expected revenue growth will likely be very detrimental to stock prices. The industry, cycle, and growth are in their early stages. Aphria (TSX:APHA)(NYSE:APHA) reported its third-quarter…

Read More

3 Ways Canopy Growth Corp (TSX:WEED) Is Overvalued

Recently, I wrote about weed company Aphria’s ambitious $1 billion sales target and the difficulty of hitting that goal. This time, I heard a similar tune from Canopy Growth (TSX:WEED)(NYSE:CGC). Being the largest publicly traded weed stock in the world, the goal of $1 billion net revenue is not ill-conceived. However, despite the $18.9 billion market cap and industry leader…

Read More